Results 251 to 260 of about 151,234 (305)
Targeting the complement system in ANCA-associated vasculitis management. [PDF]
de Groot K.
europepmc +1 more source
Scleritis and associated systemic diseases: contribution of systemic examination, follow-up, and additional investigations. [PDF]
Soubrier M +7 more
europepmc +1 more source
Microscopic polyangiitis complicated with pulmonary hepatitis B virus infection: A case report and literature review. [PDF]
Liao R, Zhang L, Wang D, Tan N.
europepmc +1 more source
Extreme thrombocytosis and ANCA-associated vasculitis in an adult patient: a case report. [PDF]
Hormaza-Jaramillo A +5 more
europepmc +1 more source
Correction: Hermenean et al. Hepatoprotective Effects of <i>Berberis vulgaris</i> L. Extract/β Cyclodextrin on Carbon Tetrachloride-Induced Acute Toxicity in Mice. <i>Int. J. Mol. Sci.</i> 2012, <i>13</i>, 9014-9034. [PDF]
Hermenean A +7 more
europepmc +1 more source
ANCA POSITIVE AND ANCA NEGATIVE MICROSCOPIC POLYARTERITIS
Adu, D +9 more
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2009
The majority of patients with Wegener's granulomatosis (WG) or microscopic polyangiitis (MPA) have antineu-trophil cytoplasmic antibodies (ANCA) in their serum. This is particularly true of patients with "disseminated" disease, the great majority of whom are ANCA positive.
Stone, John H. +7 more
openaire +1 more source
The majority of patients with Wegener's granulomatosis (WG) or microscopic polyangiitis (MPA) have antineu-trophil cytoplasmic antibodies (ANCA) in their serum. This is particularly true of patients with "disseminated" disease, the great majority of whom are ANCA positive.
Stone, John H. +7 more
openaire +1 more source

